LAS100977, A Novel Beta-2 Receptor Agonist, With A Longer Duration Of Action And More Favourable Safety Margin Than Salmeterol In Anesthetised Dogs

Autor:	Jesús Llenas, Carlos Puig, Hamish Ryder, Mònica Aparici, Amadeu Gavaldà, Jordi Gras, Montserrat Miralpeix, Marisa Viñals, Jorge Beleta, Mireia Gómez-Angelats
Rok vydání:	2010
Předmět:	Agonist medicine.drug_class business.industry Anesthesia medicine Safety margin Salmeterol Pharmacology Beta (finance) Receptor business medicine.drug
Zdroj:	D34. NOVEL THERAPEUTIC OPTIONS IN AIRWAYS DISEASE.
Databáze:	OpenAIRE
Externí odkaz:	https://explore.openaire.eu/search/publication?articleId=doi_________::495eb9ef7e41aba740d9ea5c88f352fe https://doi.org/10.1164/ajrccm-conference.2010.181.1_meetingabstracts.a5676 Zobrazit plný text záznamu